High-resolution melting analysis for a reliable and two-step scanning of mutations in the tyrosine kinase domain of the chimerical bcr-abl gene

International Journal of Hematology

Volumn 90, Issue 1, 2009, Pages 37-43

  Doi, Yuko ^a   Sasaki, Daisuke ^a   Terada, Chiharu ^a   Mori, Sayaka ^a   Tsuruda, Kazuto ^a   Matsuo, Emi ^a   Miyazaki, Yasushi ^a   Nagai, Kazuhiro ^a   Hasegawa, Hiroo ^a   Yanagihara, Katsunori ^a   Yamada, Yasuaki ^a   Kamihira, Shimeru ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Bcr abl; HRM; Melting analysis; Mutation; Ph

Indexed keywords

ABELSON KINASE; BREAKPOINT CLUSTER REGION PROTEIN; DNA; PROTEIN TYROSINE KINASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BIOASSAY; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; GENE SEQUENCE; HIGH RESOLUTION MELTING; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; PH MEASUREMENT; POLYMERASE CHAIN REACTION; PROTEIN DOMAIN; SCREENING; SENSITIVITY ANALYSIS; VALIDATION STUDY;

DNA MUTATIONAL ANALYSIS; FEMALE; FUSION PROTEINS, BCR-ABL; GENES, ABL; HUMANS; JURKAT CELLS; K562 CELLS; LEUKEMIA; MALE; MUTATION; PHILADELPHIA CHROMOSOME; PIPERAZINES; POLYMERASE CHAIN REACTION; PROTEIN KINASE INHIBITORS; PROTEIN STRUCTURE, TERTIARY; PROTEIN-TYROSINE KINASES; PYRIMIDINES; U937 CELLS;

EID: 70350571280     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-009-0337-y     Document Type: Article

References (15)

1. SG O'Brien F Guilhot RA Larson I Gathmann M Baccarani F Cervantes JJ Cornelissen T Fischer A Hochhaus T Hughes K Lechner JL Nielsen P Rousselot J Reiffers G Saglio J Shepherd B Simonsson A Gratwohl JM Goldman H Kantarjian K Taylor G Verhoef AE Bolton R Capdeville BJ Druker IRIS investigators 2003 Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia N Engl J Med 348 994 1004 10.1056/NEJMoa022457 12637609 10.1056/NEJMoa022457 (Pubitemid 36302244)
2. E Matsuo Y Miyazaki C Tsutsumi Y Inoue R Yamasaki T Hata T Fukushima H Tsushima D Imanishi Y Imaizumi M Iwanaga M Sakai K Ando Y Sawayama D Ogawa Y Kawaguchi K Nagai K Tsukasaki S Ikeda Y Moriuchi S Yoshida M Honda J Taguchi Y Onimaru T Tsuchiya M Tawara S Atogami M Yamamura H Soda Y Yoshida Y Matsuo H Nonaka T Joh Y Takasaki C Kawasaki S Momita I Jinnai K Kuriyama M Tomonaga 2007 Imatinib provides durable molecular and cytogenetic responses in a practical setting for both newly diagnosed and previously treated chronic myelogenous leukemia: a study in Nagasaki Prefecture, Japan Int J Hematol 85 132 139 10.1532/IJH97.06157 17321991 10.1532/IJH97.06157 1:CAS:528:DC%2BD2sXjvV2rtLo%3D (Pubitemid 46365550)
3. Hughes T. ABL kinase inhibitor therapy for CML: baseline assessments and response monitoring. Hematology. 2006;211-8. American Society of Hematology.
4. T Hughes M Deininger A Hochhaus S Branford J Radich J Kaeda M Baccarani J Cortes NC Cross BJ Druker J Gabert D Grimwade R Hehlmann S Kamel-Reid JH Lipton J Longtine G Martinelli G Saglio S Soverini W Stock JM Goldman 2006 Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results Blood 108 28 37 10.1182/blood-2006-01-0092 16522812 10.1182/blood-2006-01-0092 1:CAS:528:DC%2BD28XmsVOmt7Y%3D (Pubitemid 43990609)
5. S Branford Z Rudzki S Walsh A Grigg C Arthur K Taylor R Herrmann KP Lynch TP Hughes 2002 High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance Blood 99 3472 3475 10.1182/blood.V99.9.3472 11964322 10.1182/blood.V99.9.3472 1:CAS:528:DC%2BD38XjtlGqtrk%3D (Pubitemid 34525335)
6. SG Willis T Lange S Demehri S Otto L Crossman D Niederwieser EP Stoffregen S McWeeney I Kovacs B Park BJ Druker MW Deininger 2005 High-sensitivity detection of BCR-ABL kinase domain mutations in imatinib-naive patients: correlation with clonal cytogenetic evolution but not response to therapy Blood 106 2128 2137 10.1182/blood-2005-03-1036 15914554 10.1182/blood-2005-03-1036 1:CAS:528:DC%2BD2MXhtVWksLvJ (Pubitemid 41291730)
7. CT Wittwer GH Reed CN Gundry JG Vandersteen RJ Prvor 2003 High-resolution genotyping by amplicon melting analysis using LCGreen Clin Chem 9 853 860 10.1373/49.6.853 10.1373/49.6.853 (Pubitemid 36623462)
8. L Zhou L Wang R Palais R Pryor CT Wittwer 2005 High-resolution DNA melting analysis for simultaneous mutation scanning and genotyping in solution Clin Chem 51 1770 1777 10.1373/clinchem.2005.054924 16189378 10.1373/clinchem.2005.054924 1:CAS:528:DC%2BD2MXhtVGmtb3K (Pubitemid 41368166)
9. MG Herrmann JD Durtschi LK Bromley CT Wittwer KV Voelkerding 2006 Amplicon DNA melting analysis for mutation scanning and genotyping: cross-platform comparison of instruments and dyes Clin Chem 52 494 503 10.1373/clinchem.2005.063438 16423901 10.1373/clinchem.2005.063438 1:CAS:528:DC%2BD28Xit1ShtLY%3D (Pubitemid 43306475)
10. KM Poláková T Lopotová H Klamová J Moravcová 2008 High-resolution melt curve analysis: initial screening for mutations in BCR-ABL kinase domain Leuk Res 32 1236 1243 10.1016/j.leukres. 2008.01.010 18308387 10.1016/j.leukres.2008.01.010
11. H Grievink KM Stowell 2008 Identification of ryanodine receptor 1 single-nucleotide polymorphisms by high-resolution melting using the LightCycler 480 System Anal Biochem 374 396 404 10.1016/j.ab.2007.11.019 18082125 10.1016/j.ab.2007.11.019 1:CAS:528:DC%2BD1cXhslGlt7o%3D
12. M Yanada J Takeuchi I Sugiura H Akiyama N Usui F Yagasaki T Kobayashi Y Ueda M Takeuchi S Miyawaki A Maruta N Emi Y Miyazaki S Ohtake I Jinnai K Matsuo T Naoe R Ohno 2006 High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR/ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group J Clin Oncol 2006 24 460 466 10.1200/JCO.2005.03.2177 10.1200/JCO.2005.03.2177 (Pubitemid 46630465)
13. J Rulcová V Zmeková Z Zemanová H Klamová J Moravcová 2007 The effect of total-ABL, GUS and B2M control genes on BCR-ABL monitoring by real-time RT-PCR Leuk Res 31 483 491 10.1016/j.leukres. 2006.07.021 16945414 10.1016/j.leukres.2006.07.021 (Pubitemid 46206088)
14. Krypuy M, Ahmed AA, Etemadmoghadam D, Hyland SJ; Australian Ovarian Cancer Study Group, DeFazio A, Fox SB, Brenton JD, Bowtell DD, Dobrovic A. High-resolution melting for mutation scanning of TP53 exons 5-8. BMC Cancer. 2007;7:168. doi: 10,1186/1471-2407-7-168.
15. K De Leeneer I Coene B Poppe A De Paepe K Claes 2008 Rapid and sensitive detection of BRCA1/2 mutations in a diagnostic setting: comparison of two high-resolution melting platforms Clin Chem 54 982 989 10.1373/clinchem.2007. 098764 18403564 10.1373/clinchem.2007.098764 (Pubitemid 351793404)